Compare · ARAY vs MDLN
ARAY vs MDLN
Side-by-side comparison of Accuray Incorporated (ARAY) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ARAY and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $58.42B, about 1053.4x ARAY ($55.5M).
- Over the past year, ARAY is down 65.7% and MDLN is up 9.1% - MDLN leads by 74.8 points.
- ARAY has been more active in the news (8 items in the past 4 weeks vs 5 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 3 for ARAY).
- Company
- Accuray Incorporated
- Medline Inc.
- Price
- $0.46-0.11%
- $44.45-0.03%
- Market cap
- $55.5M
- $58.42B
- 1M return
- +18.79%
- +1.00%
- 1Y return
- -65.73%
- +9.09%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2007
- 2025
- News (4w)
- 8
- 5
- Recent ratings
- 3
- 25
Accuray Incorporated
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables the delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, including the Radixact System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. It markets its products in the United States directly, as well as through sales organizations, sales agents, and group purchasing organizations; and directly, as well as through distributors and sales agents in Europe, Asia, and South America to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.
Latest ARAY
- Accuray Incorporated filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
- Amendment: SEC Form SCHEDULE 13D/A filed by Accuray Incorporated
- SEC Form 3 filed by new insider Tcw Group Inc
- SEC Form 3 filed by new insider Miele Paul Michael
- Accuray Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Accuray Incorporated filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Accuray Appoints Paul Miele as Senior Vice President and Chief Commercial Officer
- SEC Form 4 filed by Chalke Sandeep
- Amendment: SEC Form SCHEDULE 13G/A filed by Accuray Incorporated
Latest MDLN
- SEC Form DEFA14A filed by Medline Inc.
- SEC Form DEF 14A filed by Medline Inc.
- Medline announces first-in-healthcare AI robotics partnership with Symbotic
- Medline to report first quarter 2026 results on May 6, 2026
- Medline launches custom product fulfillment technology called Pick Pack Pro™
- Medline recognizes manufacturing facilities with Golden Cone Safety Award
- Medline receives HIRC Member Choice Awards for supply chain achievement and renews Transparency Badge distinction
- Director Healy Patrick J acquired 577,510 shares, increasing direct ownership by 73% to 1,208,159 units (SEC Form 4)
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,058,524,148 worth of shares (26,131,237 units at $40.51) and disposed of 2,088,086 shares (SEC Form 4)
- Large owner Cp Circle Ml Holdco Gp, Llc sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)